FDA Inspection 971470 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3003103935

The FDA completed an inspection of Biomat USA, Inc. on November 20, 2015 in Danville, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 20, 2015
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Danville, VA (United States)

Citations

IDCFRDescription
4121 CFR 606.40(a)(1)Provide space for examination